Categories Earnings, Industrials
Kansas City Southern’s stock climbs after Q1 results top expectations
Kansas City Southern (NYSE: KSU) surpassed analysts’ expectations on revenue and earnings for the first quarter of 2019, sending shares climbing over 3% in morning hours on Wednesday.
Total revenues increased 6% year-over-year to $675 million. However, carload volumes fell 1%, mainly due to service interruption at Lazaro Cardenas.
On a reported basis, net income available to common stockholders dropped to $103 million, or $1.02 per share, from $144 million, or $1.40 per share, in the prior-year period, hurt by higher operating expenses. Adjusted EPS rose 18% year-over-year to $1.54.
Kansas City recorded revenue increases across most of its commodity groups with the highest in Chemical & Petroleum. Chemical & Petroleum revenues rose 21% year-over-year to $168.6 million, helped by refined product shipments to Mexico.
Agriculture & Minerals saw revenue growth of 8% due to improved network cycle times. Revenues declined in Intermodal and Automotive by 12% and 4%, respectively, due to auto plant shutdowns and teacher protests.
During the quarter, total carloads and units increased in the Chemical & Petroleum, Agriculture & Minerals, and Energy commodity groups while the remaining groups posted declines. The highest increase was in Chemical & Petroleum at 17%.
Revenue per carload/unit increased in the Chemical & Petroleum, Industrial & Consumer Products and Automotive commodity groups. Agriculture & Minerals saw a decline while Energy remained flat compared to the year-ago period.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company